Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:55 PM ET 10-Q
Financial Results Apollo Origination II (Levered) Capital Trust

Apollo Origination II Q3 2026 Results: Net Income $21.3M, Up 13.4% YoY

For the nine months ended September 30, 2026, Apollo Origination II (Levered) Capital Trust reported total investment income of $101.9 million and net investment income of $51.3 million. Total net assets grew to $835.9 million, driven by $105 million in net proceeds from common share issuances, despite a net change in unrealized losses of $12.4 million during the period.

Key figure
Net income $21.3M · +13.4% YoY
4:55 PM ET 8-K
M&A Deal Bunker Hill Mining Corp. BHLL

Bunker Hill Silver M&A Deal with Silver47 Exploration Corp.

Bunker Hill Silver Corp. completed its acquisition of Silver47 Exploration Corp. via a court-approved plan of arrangement, making Silver47 a wholly owned subsidiary. Silver47 shareholders received 0.1724 Bunker Hill shares for each Silver47 share held, creating a combined U.S. silver and critical minerals producer with a pro forma market capitalization of approximately $158 million.

Counterparty
Silver47 Exploration Corp.

“This merger represents a transformational and timely opportunity to create a leading American mining company focused on strengthening the US domestic metal supply chains at a time of intensifying global competition. I congratulate all our shareholders and the wider stakeholder community for supporting this important step forward for the Combined Company, and its potential to contribute to the revitalization of the US Mining Industry.”

Richard Williams, Executive Chairman of Bunker Hill

“Bunker Hill and Silver47 shareholders now own a compelling silver and critical mineral story in the United States: a producing mine in the Silver Valley and a pipeline of high-grade projects at Red Mountain, Hughes and Mogollon. With silver on the U.S. critical minerals list and strong support for domestic mining, we have the assets, the team and the timing to build a leading American silver producer. Thank you to all our shareholders. We are excited to get to work.”

Galen McNamara, President and Chief Investment Officer of Bunker Hill
4:54 PM ET 8-K
Dividend Orchid Island Capital, Inc. ORC

Orchid Island Capital Dividend

Orchid Island Capital declared a monthly cash dividend of $0.10 per share for November 2026, payable on December 31, 2026. The company also provided an operational update estimating its book value per share at $6.52 to $6.54 as of November 6, 2026, representing an 8-9% increase from September 30.

Term
month of November 2026
4:53 PM ET 10-Q
Financial Results T Series BDC LLC

T Series BDC Q3 2026 Results: Net Income $9.25M, Down 59.7% YoY

T Series BDC LLC's Form 10-Q for the period ended September 30, 2026, details its financial performance and investment activity as a business development company. The filing highlights net investment income, changes in net assets from operations, and the current fair value of its private debt and equity portfolio.

Key figure
Net income $9.25M · -59.7% YoY
4:52 PM ET 10-Q
Financial Results Petmed Express Inc PETS

Petmed Express Q2 2026 Results: Net Loss of $6.43M, Loss Narrows

PetMed Express reported a significant decline in net sales of 19.6% for the six months ended September 30, 2026, resulting in a net loss of $12.6 million. Management identified substantial doubt about the company's ability to continue as a going concern due to declining cash balances and ongoing operating losses, though they believe strategic cost reductions and marketing optimizations will alleviate these concerns.

Key figure
Net loss $6.43M
4:52 PM ET Form 4
Insider Selling Edwards Lifesciences Corp EW

Edwards Lifesciences Cvp, Tavr Daniel J. Lippis Sells $64.5K of Stock

Daniel J. Lippis, Cvp, Tavr, sold 619 shares of Edwards Lifesciences Corp at $104.25 a share, worth $64.5K in total on Nov 10, 2026. Shares held after the trade: 40,034 (-1.5%).

Value
$64.5K
Shares
619
Price
$104.25
Role
Cvp, Tavr
Holding change
-1.5%
Trade date
Nov 10, 2026
4:51 PM ET 8-K
Financial Results Gossamer Bio, Inc. GOSS

Gossamer Bio Financial Results

Gossamer Bio reported Q3 2026 financial results, highlighting the submission of its first New Drug Application (NDA) to the FDA for seralutinib in PAH. The company also noted a structured private placement that provided $25 million upfront and could unlock an additional $125 million upon FDA acceptance of the NDA. Additionally, the company completed a 1-for-80 reverse stock split in September 2026 to regain Nasdaq compliance.

Term
Q3 2026

“Submitting our first NDA marks an important milestone for Gossamer in our continued efforts to bring seralutinib to patients living with PAH. Furthermore, FDA acceptance of the application in 2026 would, subject to other customary closing conditions, unlock up to approximately $125 million in additional committed capital to support our priorities, including preparations for a potential launch. We remain focused on supporting the FDA’s review and preparing for a potential commercial launch of seralutinib in 2027.”

Faheem Hasnain, Chairman, Co-Founder and Chief Executive Officer
4:51 PM ET Form 4
Insider Selling Circle Internet Group, Inc. CRCL

Circle Internet Group Chief Product & Tech. Officer Nikhil Chandhok Sells $1.76M of Stock

Nikhil Chandhok, Chief Product & Tech. Officer, sold 26,668 shares of Circle Internet Group, Inc. at $66.09 a share, worth $1.76M in total on Nov 9, 2026. Shares held after the trade: 708,181 (-3.6%).

Value
$1.76M
Shares
26,668
Price
$66.09
Role
Chief Product & Tech. Officer
Holding change
-3.6%
Trade date
Nov 9, 2026
4:51 PM ET 10-Q
Financial Results Abvc Biopharma, Inc. ABVC

Abvc Biopharma Q3 2026 Results: Turns Profitable, Net Income $1.15M

ABVC BioPharma reported accrued research and development expenses of $1,741,083 as of September 30, 2026, primarily for manufacturing and process development. The company noted potential increases in future accruals due to the planned resumption of ophthalmology and CNS clinical trials.

Key figure
Net income $1.15M
4:51 PM ET 8-K
Nasdaq/NYSE Compliance Notice Rent the Runway, Inc. RENT

Rent the Runway Nasdaq/NYSE Compliance Notice

Rent the Runway received a deficiency notice from Nasdaq on November 4, 2026, because its market value of publicly held shares (MVPHS) fell below the $15 million minimum requirement for 39 consecutive business days. The company has 180 calendar days, until May 3, 2027, to regain compliance by maintaining a MVPHS of at least $15 million for ten consecutive business days. The company is evaluating options to resolve the deficiency, including a potential transfer to The Nasdaq Capital Market.

Counterparty
Nasdaq
Term
180 days
4:49 PM ET 10-Q
Financial Results Gossamer Bio, Inc. GOSS

Gossamer Bio Q3 2026 Results: Net Loss of $48.1M, Loss Narrows

Gossamer Bio reported total revenue of $64.6 million for the nine months ended September 30, 2026, compared to $34.7 million in the prior year, primarily driven by collaboration contracts. Despite the revenue growth, the company recorded a net loss of $77.8 million for the period, impacted by significant non-cash items including a $54.9 million remeasurement of warrant liability and a $43.8 million gain on debt extinguishment.

Key figure
Net loss $48.1M
4:48 PM ET 10-Q
Financial Results Autolus Therapeutics plc AUTL

Autolus Therapeutics Q3 2026 Results: Net Loss of $55.1M, Loss Narrows

Autolus Therapeutics plc, a foreign private issuer voluntarily filing a Form 10-Q, reported 266,340,330 ordinary shares outstanding as of November 9, 2026. The filing highlights the commercialization of AUCATZYL for adult r/r B-ALL and notes a restructuring and workforce reduction plan initiated in April 2026.

Key figure
Net loss $55.1M
4:48 PM ET 10-Q
Financial Results Metropolitan Life Insurance Co

Metropolitan Life Insurance Q3 2026 Results: Net Income $1.5B, Up 190.1% YoY

Metropolitan Life Insurance Company reported total assets of $375.9 billion as of September 30, 2026, a decrease from $383.5 billion at year-end 2025. Stockholder's equity declined to $12.4 billion, primarily driven by an increase in accumulated other comprehensive loss, while the company continues to operate as a wholly-owned subsidiary of MetLife, Inc. under a reduced disclosure format.

Key figure
Net income $1.5B · +190.1% YoY
4:47 PM ET 10-Q
Financial Results Hyliion Holdings Corp. HYLN

Hyliion Holdings Q3 2026 Results: Net Loss of $11.1M, Loss Narrows

Hyliion Holdings Corp. reported a net loss of $11.1 million for the third quarter of 2026, an improvement from the $13.3 million loss in the prior year period. Total revenues grew significantly to $7.5 million, primarily driven by research and development services, while the company continues to transition its focus toward the KARNO Power Module technology.

Key figure
Net loss $11.1M
4:47 PM ET Form 4
Insider Selling Seacoast Banking Corp of Florida SBCF

Seacoast Banking Corp of Florida Insider Dennis S. Hudson III Sells $34.3K of Stock

Dennis S. Hudson III sold 1,000 shares of Seacoast Banking Corp of Florida at $34.31 a share, worth $34.3K in total on Nov 9, 2026. Shares held after the trade: 8,356 (-10.7%).

Value
$34.3K
Shares
1,000
Price
$34.31
Holding change
-10.7%
Trade date
Nov 9, 2026
4:47 PM ET 8-K
Financial Results Azenta, Inc. AZTA

Azenta Financial Results

Azenta reported fiscal fourth quarter and full year 2026 results, with Q4 revenue growing 5% year-over-year to $167 million. The company completed the sale of its B Medical Systems business during the year and is focusing on driving organic growth and profitability in its Multiomics and Sample Management segments for fiscal 2027.

Term
FY2026

“We closed fiscal 2026 with improving momentum, delivering stronger performance in the second half of the year. Our businesses have strong market positions and differentiated capabilities, and we are seeing progress from our efforts to improve commercial execution and operating efficiency.”

Dr. Martin Madaus, Interim President and Chief Executive Officer

“Fiscal 2027 is about consistent execution and accelerating performance. We are focused on driving organic growth, expanding profitability and cash generation, and executing on our strategic initiatives.”

Dr. Martin Madaus, Interim President and Chief Executive Officer
4:46 PM ET Form 4
Insider Selling Jazz Pharmaceuticals plc JAZZ

Jazz Pharmaceuticals Insider Bruce C. Cozadd Sells $16.2M of Stock

Bruce C. Cozadd sold 68,808 shares of Jazz Pharmaceuticals plc at $234.91 to $237.39 a share (average $235.95) in 4 transactions, worth $16.2M in total on Nov 6, 2026. Shares held after the trade: 357,567 (-1.6%).

Value
$16.2M
Shares
68,808
Average price
$235.95
Holding change
-1.6%
Trade date
Nov 6, 2026
4:46 PM ET 10-Q
Financial Results North Haven Private Income Fund A LLC

North Haven Private Income Fund A Q3 2026 Results: Net Income $4.79M, Down 27.2% YoY

North Haven Private Income Fund A LLC reported a net increase in members' capital resulting from operations of $12.4 million for the nine months ended September 30, 2026, down from $16.9 million in the prior year period. The decrease was primarily driven by $9.1 million in net realized and unrealized losses, which offset a significant rise in total investment income to $40.8 million.

Key figure
Net income $4.79M · -27.2% YoY
4:46 PM ET Form 4
Insider Selling Ridgepost Capital, Inc. RPC

Ridgepost Capital Insider Andrew Rowan Nelson Sells $97.7K of Stock

Andrew Rowan Nelson sold 10,000 shares of Ridgepost Capital, Inc. at $9.77 a share, worth $97.7K in total on Nov 6, 2026. Shares held after the trade: 55,334 (-15.3%).

Value
$97.7K
Shares
10,000
Price
$9.77
Holding change
-15.3%
Trade date
Nov 6, 2026
4:46 PM ET 8-K
Financial Results Hyliion Holdings Corp. HYLN

Hyliion Holdings Financial Results

Hyliion Holdings reported Q3 2026 revenue of $7.5 million and increased its full-year 2026 revenue guidance to approximately $18 million. The company delivered an early adopter KARNO Power Module to the U.S. Navy and expects to secure approximately $50 million in total military contract awards for the full year.

Term
Q3 2026

“We delivered another strong quarter, with revenue well above our expectations and continued progress on system performance and customer deployments. We delivered another system to the Navy and began moving equipment to our first commercial customer site, where we expect to complete the deployment in the weeks ahead.”

Thomas Healy, Founder and CEO
4:46 PM ET 10-Q
Financial Results Beachbody Company, Inc. BODI

Beachbody Company Q3 2026 Results: Net Income $3.28M, Down 8.1% YoY

Beachbody reported a net income of $6.95 million for the nine months ended September 30, 2026, a significant improvement from the $8.08 million net loss in the prior year period. Total revenue decreased from $196.2 million to $149.1 million year-over-year, but the company achieved profitability through substantial reductions in selling, marketing, and general administrative expenses.

Key figure
Net income $3.28M · -8.1% YoY
4:46 PM ET 8-K
M&A Deal InMed Pharmaceuticals Inc. MTRI

InMed Pharmaceuticals Signs $490M M&A Deal with Mentari Therapeutics, Inc.

InMed Pharmaceuticals Inc. (renamed Mentari Therapeutics, Inc.) completed its business combination with private Delaware corporation Mentari Therapeutics, Inc. on November 6, 2026. The transaction included a pre-closing financing that raised $490 million in aggregate gross proceeds. The combined company will focus on developing therapies for migraine prevention and is led by the Mentari management team.

Value
$490M
Counterparty
Mentari Therapeutics, Inc.
4:46 PM ET 10-Q
Financial Results Sanuwave Health, Inc. SNWV

Sanuwave Health Q3 2026 Results: Net Loss of $1.42M

SANUWAVE Health reported a net operating loss of $2.5 million for the nine months ended September 30, 2026, compared to an operating income of $2.9 million in the prior year period. Total revenue decreased to $27.9 million from $30.7 million, while operating expenses increased primarily due to higher research and development and selling costs.

Key figure
Net loss $1.42M
4:45 PM ET 8-K
Loan & Debt Chesapeake Utilities Corp CPK

Chesapeake Utilities $250M Debt Financing with purchasers named therein

Chesapeake Utilities Corporation entered into a Note Purchase Agreement for the sale of $250 million in aggregate principal amount of unsecured senior notes. The issuance consists of three series with maturities ranging from 2029 to 2036 and interest rates between 5.74% and 6.09%. $150 million of the notes funded on November 10, 2026, with the remaining $100 million expected to fund in December 2026.

Value
$250M
Counterparty
purchasers named therein
Term
through Dec 2036
4:45 PM ET Form 4
Insider Selling Verisign Inc VRSN

Verisign EVP, Gen Counsel & Secretary Thomas C. Indelicarto Sells $155K of Stock

Thomas C. Indelicarto, EVP, Gen Counsel & Secretary, sold 500 shares of Verisign Inc at $310.07 a share, worth $155K in total on Nov 9, 2026. Shares held after the trade: 30,895 (-1.6%).

Value
$155K
Shares
500
Price
$310.07
Role
EVP, Gen Counsel & Secretary
Holding change
-1.6%
Trade date
Nov 9, 2026
4:45 PM ET 10-Q
Financial Results Koru Medical Systems, Inc. KRMD

Koru Medical Systems Q3 2026 Results: Turns Profitable, Net Income $218K

KORU Medical Systems reported net revenues of $11.6 million for the quarter ended September 30, 2026, representing growth over the $10.4 million reported in the prior year period. The company achieved a net income of $0.2 million for the quarter, a significant improvement from the $0.8 million net loss in the same period of 2025.

Key figure
Net income $218K
4:45 PM ET 8-K
Capital Raise Crypto Co CRCW

Crypto Capital Raise

The Crypto Company entered into subscription agreements to sell 84,210,128 shares of common stock for an aggregate purchase price of $65,000. The consideration consisted of $50,000 in cash plus 1.4 ETH and 0.16 BTC. One of the investors, Three Mile Creek Future LLC, is managed by the company's Chief Strategy Officer, Rafael Furst.

Counterparty
Three Mile Creek Future LLC and Nikola Stein
4:44 PM ET 8-K
Financial Results Tandy Leather Factory Inc TLF

Tandy Leather Factory Financial Results

Tandy Leather Factory reported third quarter 2026 revenues of $18.5 million, a 7.3% increase year-over-year, and returned to profitability with net income of $0.5 million. The company highlighted operational improvements and store expansions in Waco, Texas, and Charleston, South Carolina, as key drivers of the 181.9% increase in operating income.

Term
Q3 2026

“We are happy to have continued our growth from the first half of the year with another strong quarter. We saw growth in both retail and e-commerce channels and considerably increased our operating income. Following our new store opening in Waco, Texas in the second quarter, we continued our store expansion in the third quarter with a new opening in Charleston, South Carolina. During the third quarter, we continued to invest in our store fleet, our e-commerce channel and operations but our sales and margin growth more than offset these expenses, driving strong increases in profit from operations.”

Johan Hedberg, Chief Executive Officer
4:44 PM ET 8-K
Financial Results Koru Medical Systems, Inc. KRMD

Koru Medical Systems Financial Results

KORU Medical Systems reported Q3 2026 net revenues of $11.6 million, an 11% increase year-over-year, and achieved its second consecutive quarter of positive net income. The company revised its full-year 2026 revenue guidance to $48.0-$48.5 million and highlighted growth in domestic core revenues driven by higher pump and consumable volumes.

Term
Q3 2026

“Total Revenue of $11.6 million represents another quarter of consistent above-market growth for KORU, driven by our recurring patient base. We also delivered positive net income and adjusted EBITDA for the second consecutive quarter, demonstrating the scalability of our business model.”

Adam Kalbermatten, President and CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.